These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18838500)

  • 1. Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants.
    Hood SD; Potokar JP; Davies SJ; Hince DA; Morris K; Seddon KM; Nutt DJ; Argyropoulos SV
    J Psychopharmacol; 2010 May; 24(5):709-16. PubMed ID: 18838500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
    Franco-Chaves JA; Mateus CF; Luckenbaugh DA; Martinez PE; Mallinger AG; Zarate CA
    J Affect Disord; 2013 Jul; 149(1-3):319-25. PubMed ID: 23517885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.
    Samuels ER; Hou RH; Langley RW; Szabadi E; Bradshaw CM
    Psychopharmacology (Berl); 2006 Sep; 187(4):498-510. PubMed ID: 16802163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.
    Ersche KD; Bullmore ET; Craig KJ; Shabbir SS; Abbott S; Müller U; Ooi C; Suckling J; Barnes A; Sahakian BJ; Merlo-Pich EV; Robbins TW
    Arch Gen Psychiatry; 2010 Jun; 67(6):632-44. PubMed ID: 20530013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers.
    Lawn W; Freeman TP; East K; Gaule A; Aston ER; Bloomfield MAP; Das RK; Morgan CJA; Curran HV
    Nicotine Tob Res; 2018 Jun; 20(7):800-809. PubMed ID: 29065193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
    Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
    Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers.
    Kaltenboeck A; Halahakoon DC; Harmer CJ; Cowen P; Browning M
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):720-726. PubMed ID: 35605609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
    Rogóz Z; Skuza G
    Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to sulpiride in social anxiety disorder: D2 receptor function.
    Bell C; Bhikha S; Colhoun H; Carter F; Frampton C; Porter R
    J Psychopharmacol; 2013 Feb; 27(2):146-51. PubMed ID: 22745189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.
    Newton TF; Haile CN; Mahoney JJ; Shah R; Verrico CD; De La Garza R; Kosten TR
    Psychiatry Res; 2015 Nov; 230(1):44-9. PubMed ID: 26239766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
    Ersche KD; Roiser JP; Abbott S; Craig KJ; Müller U; Suckling J; Ooi C; Shabbir SS; Clark L; Sahakian BJ; Fineberg NA; Merlo-Pich EV; Robbins TW; Bullmore ET
    Biol Psychiatry; 2011 Oct; 70(8):754-762. PubMed ID: 21967987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.
    Corrigan MH; Denahan AQ; Wright CE; Ragual RJ; Evans DL
    Depress Anxiety; 2000; 11(2):58-65. PubMed ID: 10812530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
    Collins GT; Calinski DM; Newman AH; Grundt P; Woods JH
    J Pharmacol Exp Ther; 2008 May; 325(2):691-7. PubMed ID: 18305018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment.
    Ersche KD; Roiser JP; Lucas M; Domenici E; Robbins TW; Bullmore ET
    Psychopharmacology (Berl); 2011 Apr; 214(4):779-89. PubMed ID: 21088959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
    Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
    J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.
    Morein-Zamir S; Craig KJ; Ersche KD; Abbott S; Muller U; Fineberg NA; Bullmore ET; Sahakian BJ; Robbins TW
    Psychopharmacology (Berl); 2010 Oct; 212(3):357-67. PubMed ID: 20661550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.
    Argyropoulos SV; Hood SD; Adrover M; Bell CJ; Rich AS; Nash JR; Rich NC; Witchel HJ; Nutt DJ
    Biol Psychiatry; 2004 Oct; 56(7):503-9. PubMed ID: 15450786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic mechanism of antidepressant action in depressed patients.
    Willner P; Hale AS; Argyropoulos S
    J Affect Disord; 2005 May; 86(1):37-45. PubMed ID: 15820269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.